Status:
COMPLETED
Effects of Enteral Supplement Vitamin D Incritically Ill Patients
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Vitamin D Deficiency
Critical Illness
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
At present, there is no clinical reference data on how much the concentration of calcifediol in the blood increases after supplementing with vitamin D for Taiwanese ICU patients. This study aims to in...
Detailed Description
Vitamin D deficiency patients have longer hospital stays, higher medical expenditures, and higher sepsis-related mortality. The preliminary results of 145 ICU patients of the Northern Medical Centers ...
Eligibility Criteria
Inclusion
- patients in intensive care units
- blood calcifediol concentration less than 20 ng / mL
- suitable for enteral feeding
- no ileus, vomit, or diarrhea
Exclusion
- younger than 20 years old
- receive high dose vitamin D within 4 weeks (\> 3000 IU pre day)
- hypercalemia ( \> 2.6 mmol/L)
- body weight \< 45 or \> 90 kg
- admitted to intensive care unit before this admission within 3 months
- have diseases as follows: parathyroid disease, rickets, or liver cirrhosis - Child C
- diagnosed with renal stone, tuberculosis, or sarcoidosis
- Non-native speaker
Key Trial Info
Start Date :
March 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT04292873
Start Date
March 16 2020
End Date
March 31 2023
Last Update
December 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100